Celebrating 50 Years of MS Innovation - User interviews

On the occasion of Shimadzu's 50th year of producing mass spectrometry instruments, we talk to researchers using Shimadzu MS instruments in their daily work and ask about their expectations for Shimadzu and the future of MS technology.

User Interview Index

Dr. Charita S. Kwan

March 2020

Dr. Charita S. Kwan
Head of the Research and Analytical Services Laboratory, Natural Sciences Research Institute, University of the Philippines Diliman

Over the past 20 years, I have become involved in the measurement of organic micropollutants, especially POPs and EDCs. In 2000, our laboratory was chosen to represent the Philippines in the ...

HTML version  

Pierre Marquet, MD, PhD

March 2020

Pierre Marquet, MD, PhD
Head of the pharmacology and toxicology department at the University Hospital of Limoges, France.

Our main research topic is personalized medicine in organ transplant recipients. More generally, we set up analytical techniques to determine drugs or toxicants in biofluids to improve patient care. ...

HTML version  

Dr. Adam Cawley

February 2020

Dr. Adam Cawley
Science Manager, Australian Racing Forensic Laboratory, Racing NSW

For the detection of peptide and protein drug molecules of interest to anti-doping we are developing methods of analysis using the Nexera Mikros Micro-Flow LC-MS-MS instrument to achieve ...

HTML version  

Prof. Marcos N. Eberlin

February 2020

Prof. Marcos N. Eberlin
MackMass – Mackenzie Laboratory for Mass Spectrometry –
Mackenzie Presbyterian University, São Paulo Brazil

My laboratory has been actively involved in ambient mass spectrometry (MS) and specifically in applying a new ionization technique (EASI) that we have developed in many fields such as ...

HTML version  

Wang Guanghui, Professor

January 2020

Wang Guanghui, Professor
National Centre for Mass Spectrometry,
Institute of Chemistry Chinese Academy of Sciences

We mainly use GC-MS and LC-MS for qualitative analysis of complex mixtures. We not only look for compounds in a spectral database, but also can carry out structure analysis on unknown ...

HTML version  

Stanley Hazen, MD, PhD

January 2020

Stanley Hazen, MD, PhD,
Section Head of Preventive Cardiology & Rehabilitation, Cleveland Clinic, USA

My research is focused on understanding the mechanisms of heart disease. To do that, we use mass spectrometry as a primary tool to discover the chemical signatures, both in the artery ...

HTML version  

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page